Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver. (Q45971609)

18 December 2017

title

Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver. (English)

1 reference

18 December 2017

author name string

Wisner ER

1

1 reference

18 December 2017

Merisko-Liversidge E

2

1 reference

18 December 2017

Kellar K

3

1 reference

18 December 2017

Katzberg RW

4

1 reference

18 December 2017

Karpinski PH

5

1 reference

18 December 2017

Amparo EG

6

1 reference

18 December 2017

Drake C

7

1 reference

18 December 2017

Griffey SM

8

1 reference

18 December 2017

Brock JM

9

1 reference

18 December 2017

publication date

1 February 1995

1 reference

18 December 2017

published in

Academic Radiology

1 reference

18 December 2017

volume

2

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

140-147

1 reference

18 December 2017

Preoperative assessment of resectability of hepatic metastases from colonic carcinoma: CT portography vs sonography and dynamic CT

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Dynamic computed tomography during arterial portography: the most sensitive examination for small hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Liver metastases from colorectal cancers: detection with CT during arterial portography

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Manganese-DPDP as a Hepatobiliary Contrast Agent in the Magnetic Resonance Imaging of Liver Tumors: Results of Clinical Phase II Trials in Germany Including 141 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Hepatobiliary MR imaging: first human experience with MnDPDP

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Hepatic contrast-enhancing properties of manganese-mesoporphyrin and manganese-TPPS4. A comparative magnetic resonance imaging study in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Metalloporphyrins as contrast agents for tumors in magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Liposome encapsulated MnCl2 as a liver specific contrast agent for magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

MR receptor imaging: ultrasmall iron oxide particles targeted to asialoglycoprotein receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Controlled environment vitrification system: an improved sample preparation technique

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Particle size analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

Transverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetite

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2805%2980149-7

7 January 2021

10.1016/S1076-6332(05)80149-7

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017